This suggests that TO may act as a novel TRAIL, sensitizing carcinoma cells to TRAIL-induced apoptosis by blocking mitogen protein kinase kinase 7-TOR signaling pathway regulator-like (MKK7-TIPRL) interaction and activating JNK [85]. Here, TIPRL is linked to carcinoma.